PURE Bioscience Reports Operating Results (10-Q)

Author's Avatar
Jun 13, 2012
PURE Bioscience (PURE, Financial) filed Quarterly Report for the period ended 2012-04-30.

Pure Bioscience has a market cap of $14.4 million; its shares were traded at around $0.31 with and P/S ratio of 31. Pure Bioscience had an annual average earning growth of 3.7% over the past 5 years.

Highlight of Business Operations:

Net product sales were $207,000 and $128,000 for the three months ended April 30, 2012 and 2011, respectively. The increase of $79,000 was primarily attributable to sales to one customer. This customer accounted for $172,000 of net product sales for the three months ended April 30, 2012.

For the three months ended April 30, 2012, one individual customer accounted for 10% or more of our net product sales. No other individual customer accounted for 10% or more of our net product sales. The geographic breakdown of net product sales was as follows: 100% U.S. and 0% foreign.

For the three months ended April 30, 2011, four individual customers each accounted for 10% or more of our net product sales. One customer accounted for 34%, another for 30%, and the third and forth for 10% each. No other individual customer accounted for 10% or more of our net product sales. The geographic breakdown of net product sales was as follows: 66% U.S. and 34% foreign.

Net product sales were $685,000 and $210,000 for the nine months ended April 30, 2012 and 2011, respectively. The increase of $475,000 was primarily attributable to sales to one customer, as well as increased sales to a few existing customers. Our top customer accounted for $498,000 of net product sales for the nine months ended April 30, 2012.

For the nine months ended April 30, 2011, four individual customers each accounted for 10% or more of our net product sales. One customer accounted for 21%, another for 20%, another for 18%, and the fourth for 17%. No other individual customer accounted for 10% or more of our net product sales. The geographic breakdown of net product sales was as follows: 79% U.S. and 21% foreign.

Read the The complete Report